Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;72(3):151-160.
doi: 10.1111/pin.13202. Epub 2022 Jan 25.

Atherosclerosis: Known and unknown

Affiliations
Review

Atherosclerosis: Known and unknown

Jianglin Fan et al. Pathol Int. 2022 Mar.

Abstract

Atherosclerotic disease, such as myocardial infarction and stroke, is the number one killer worldwide. Atherosclerosis is considered to be caused by multiple factors, including genetic and environmental factors. In humans, it takes several decades until the clinical complications develop. There are many known risk factors for atherosclerosis, including hypercholesterolemia, hypertension, diabetes and smoking, which are involved in the pathogenesis of atherosclerosis; however, it is generally believed that atherosclerosis is vascular chronic inflammation initiated by interactions of these risk factors and arterial wall cells. In the past 30 years, the molecular mechanisms underlying the pathogenesis of atherosclerosis have been investigated extensively using genetically modified animals, and lipid-reducing drugs, such as statins, have been demonstrated as the most effective for the prevention and treatment of atherosclerosis. However, despite this progress, questions regarding the pathogenesis of atherosclerosis remain and there is a need to develop new animal models and novel therapeutics to treat patients who cannot be effectively treated by statins. In this review, we will focus on two topics of atherosclerosis, "pathology" and "pathogenesis," and discuss unanswered questions.

Keywords: animal models; atherosclerosis; hypercholesterolemia; pathology.

PubMed Disclaimer

References

REFERENCES

    1. Thompson RC , Allam AH , Lombardi GP , Wann LS , Sutherland ML , Sutherland JD , et al. Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations. Lancet. 2013;381:1211-22.
    1. Allam AH , Thompson RC , Wann LS , Miyamoto MI , Nur E-DA-H , El-Maksoud GA , et al. Atherosclerosis in ancient Egyptian mummies: the Horus study. JACC Cardiovasc Imaging. 2011;4:315-27.
    1. Imakita M , Yutani C , Strong JP , Sakurai I , Sumiyoshi A , Watanabe T , et al. Second nation-wide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis. 2001;155:487-97.
    1. Nakashima Y , Chen YX , Kinukawa N , Sueishi K . Distributions of diffuse intimal thickening in human arteries: preferential expression in atherosclerosis-prone arteries from an early age. Virchows Arch. 2002;441:279-88.
    1. Tanaka K , Masuda J , Imamura T , Sueishi K , Nakashima T , Sakurai I , et al. A nation-wide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis. 1988;72:143-56.

LinkOut - more resources